U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06394349) titled 'Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo' on April 24.

Brief Summary: The goal of this clinical trial is to learn if platelet-rich plasma (PRP) works to treat acral stable vitiligo in adults. It will also learn about the safety of platelet-rich plasma. The main questions it aims to answer are:

* Does PRP combined with 308 nm excimer phototherapy improve the efficacy compared to 308 nm excimer light alone in the treatment of vitiligo of the extremities?

* What medical problems do participants have when taking PRP intradermal injections?

Researchers will compare ...